LRRK2 and Parkinson disease: The figures of 40% sensitivity and 80% specificity (the lowest of published studies of alpha-synuclein RT-QuIC) from a study of LRRK2-associated Parkinson’s disease might appear discouraging (Garrido et al., 2019).